Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil for Habit Modification in Anorexia Nervosa
NCT06518941Phase 2Not yet recruiting
- Sponsor
- New York State Psychiatric Institute
- Start
- Jan 2027
- Primary completion
- Jun 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of donepezil in anorexia nervosa (AN), sponsored by New York State Psychiatric Institute. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
donepezil
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on NCT06518941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06518941.